Lv2
120 积分 2023-03-16 加入
Long‐term efficacy of abrocitinib in patients with moderate‐to‐severe atopic dermatitis to 2 years
14小时前
待确认
Peficitinib halts acute kidney injury via JAK/STAT3 and growth factors immunomodulation
1个月前
已完结
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Clinical characteristics and causes of pruritus in cats: a multicentre study on feline hypersensitivity‐associated dermatoses
2个月前
已完结
Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
3个月前
已完结
Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis
3个月前
已完结
Prevalence, risk factors and management approaches for seborrheic dermatitis
3个月前
已完结
Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology
3个月前
已完结
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trial
4个月前
已完结
皖公网安备34019202002308
